Companies: 10,795·Total market cap: $144.5T
CSL Limited

CSL Limited

CMXHFOTCHealthcare● Active
$70.66
+$0.12(+0.17%)
Market Cap$33.8B
P/E Ratio
52W High$184.09
52W Low$63.99
Overview

CSL Limited (CMXHF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CMXHF · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$15.43B$14.80B$13.17B$10.49B$10.27B
Cost of Revenue$7.48B$7.13B$6.47B$4.83B$4.47B
Gross Profit$7.95B$7.56B$6.71B$5.66B$5.74B
Gross Margin %(computed)51.53%51.09%50.92%53.97%55.91%
Operating Expenses
R&D Expenses$1.36B$1.45B$1.24B$1.16B$0.75B
G&A Expenses$1.00B$0.86B$1.09B$0.69B$0.73B
Total Operating Expenses$4.99B$4.80B$3.93B$3.35B$2.41B
Operating Income$2.96B$3.81B$2.90B$2.92B$2.59B
Operating Margin %(computed)19.18%25.76%22.04%27.85%25.23%
Interest Income$0.04B$0.04B$0.04B$0.02B$0.00B
Interest Expense$0.45B$0.48B$0.44B$0.16B$0.17B
Income Before Tax$3.72B$3.38B$2.66B$2.78B$2.96B
Income Tax Expense$0.59B$0.66B$0.42B$0.52B$0.44B
Net Income$3.00B$2.64B$2.19B$2.25B$1.78B
Net Margin %(computed)19.46%17.85%16.65%21.49%17.37%
Per Share & EBITDA
EPS (Basic)$6.20$5.47$4.55$4.81$3.94
Wtd Avg Shares0.48B0.48B0.48B0.47B0.45B
EBITDA$5.13B$4.73B$3.90B$3.46B$3.63B
EBITDA Margin %(computed)33.27%31.98%29.62%33.02%35.35%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more CSL Limited data

About CSL Limited (CMXHF) Income Statement

CSL Limited (CMXHF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CMXHF reported revenue of $15.43B, gross profit of $7.95B (gross margin 51.53%), and net income of $3.00B — a net profit margin of 19.46%.

Frequently asked questions

CMXHF · 4 questions

CSL Limited (CMXHF) reported revenue of $15.43B for 2025, up 4.3% year-over-year.

CMXHF revenueCMXHF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08